Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...
Research Antibodies Market. The global research antibodies market is on a trajectory of significant expansion, driven by the ...
Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for collaboration on supply chain efficiencies, services, and joint product ...
Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...
Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...